Home - Products - Others - Other Targets - Dihydrodehydrodiconiferyl alcohol-9-O-β-d-glucopyranoside

Dihydrodehydrodiconiferyl alcohol-9-O-β-d-glucopyranoside

CAS No. 1992045-13-2

Dihydrodehydrodiconiferyl alcohol-9-O-β-d-glucopyranoside( ——— )

Catalog No. M38335 CAS No. 1992045-13-2

Dihydrodehydrodiconiferyl alcohol-9′-O-β-d-glucopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dihydrodehydrodiconiferyl alcohol-9-O-β-d-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrodehydrodiconiferyl alcohol-9′-O-β-d-glucopyranoside
  • Description
    Dihydrodehydrodiconiferyl alcohol-9′-O-β-d-glucopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1992045-13-2
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TNG908

    TNG908 is an orally active and selective MTAP-co-PRMT5 inhibitor that crosses the blood-brain barrier and kills MTAP-deficient cancers.

  • Terrestrosin D

    Terrestrosin D can induce apoptotic cell death and inhibit angiogenesis in xenograft tumor cells, cell cycle arrest and induction of apoptosis in cancer cells and endothelial cells might be plausible mechanisms of actions for the observed antitumor and antiangiogenic activities of terrestrosin D.

  • Azelaprag

    Azelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases.